ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686556 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686556; 2) Community: the network communities that were significantly associated with the response to NSC 686556; 3) Molecule: the relationships between components within communities and NSC 686556; 4) MDR: the compounds that were significantly associated with the NSC 686556.

NSC Compound Enrichment Correlation
NSC 1393 4-APP 0.0339770934764509 -0.064662987
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0339770934764509 0.19043828
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0339770934764509 0.38342112
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0339770934764509 0.35994667
NSC 3060 Arsenenous acid, potassium salt (9CI) 0.0339770934764509 0.16228291
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0339770934764509 0.33851261
NSC 329691 HM-4 0.0339770934764509 0.18112448
NSC 352330 Bis(helenalinyl)glutarate 0.0339770934764509 0.084481968
NSC 362453 Butanedioic acid, mono[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl]ethyl] ester 0.0339770934764509 0.41152948
NSC 382049 2,4-Pyrimidinediamine, 6-ethyl-5-[3-nitro- 4-[(2-phenylethyl)amino]phenyl]- 0.0339770934764509 0.40423551
Total:84  Current:54    [First] [Prev] [Next] [Last]